Menopausal Hormone Therapy: Its Role in the Prevention of Cardiovascular Diseases and the Risk of Breast Cancer in Women
Objective: This review was conducted to explain how menopausal hormone therapy (MHT) benefits cardiovascular diseases (CVDs) and how to control the risk of breast cancer. Mechanism: Estrogen deficiency, altered...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
IMR Press
2025-01-01
|
| Series: | Clinical and Experimental Obstetrics & Gynecology |
| Subjects: | |
| Online Access: | https://www.imrpress.com/journal/CEOG/52/1/10.31083/CEOG26813 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832586571514118144 |
|---|---|
| author | Tam Thai Thanh Tran Thu Minh Phung Anh Thi Mai Do Quynh Tran Mai Ly Tin Hoang Nguyen |
| author_facet | Tam Thai Thanh Tran Thu Minh Phung Anh Thi Mai Do Quynh Tran Mai Ly Tin Hoang Nguyen |
| author_sort | Tam Thai Thanh Tran |
| collection | DOAJ |
| description | Objective: This review was conducted to explain how menopausal hormone therapy (MHT) benefits cardiovascular diseases (CVDs) and how to control the risk of breast cancer. Mechanism: Estrogen deficiency, altered energy homeostasis, adipocyte changes, inflammation, and insulin resistance are responsible for the development of metabolic syndrome and CVDs. Estrogen influences hypothalamic function and maintains the energy balance, protecting menopausal women from these cardiovascular risk factors. However, estrogen metabolism plays a crucial role in the genotoxic pathway that leads to breast cancer. Moreover, MHT is associated with cell proliferation and mutation signaling pathways in breast cancer, as well as the process of growing the breast cancer stem cell. Findings in Brief: While MHT may have favorable effects when started early, introducing it later in the course of atherosclerosis may pose major dangers, underlining the importance of timing in hormone therapy. Estrogen-only therapy has a greater favorable effect on CVDs than the estrogen-progesterone combination. Although the connection between MHT and breast cancer is well-documented, significant knowledge gaps remain, especially regarding the long-term effects of newer MHT formulations. Current studies support using the lowest effective dose for the shortest possible duration, with a focus on tailoring therapy to individual risk factors, such as obesity, smoking, and alcohol consumption. Thus, MHT should be customized due to the intricacy of individual risk factors and differences in responses to therapy. Conclusions: Although MHT is effective for controlling CVDs in women entering menopause, it must be used with caution, especially in women at high risk of breast cancer. |
| format | Article |
| id | doaj-art-55a8ca3d858f44b8a82a23df4b160a79 |
| institution | Kabale University |
| issn | 0390-6663 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | IMR Press |
| record_format | Article |
| series | Clinical and Experimental Obstetrics & Gynecology |
| spelling | doaj-art-55a8ca3d858f44b8a82a23df4b160a792025-01-25T07:14:26ZengIMR PressClinical and Experimental Obstetrics & Gynecology0390-66632025-01-015212681310.31083/CEOG26813S0390-6663(24)02548-XMenopausal Hormone Therapy: Its Role in the Prevention of Cardiovascular Diseases and the Risk of Breast Cancer in WomenTam Thai Thanh Tran0Thu Minh Phung1Anh Thi Mai Do2Quynh Tran Mai Ly3Tin Hoang Nguyen4Faculty of Medicine, Can Tho University of Medicine and Pharmacy, 900000 Can Tho, VietnamFaculty of Medicine, Can Tho University of Medicine and Pharmacy, 900000 Can Tho, VietnamFaculty of Medicine, Can Tho University of Medicine and Pharmacy, 900000 Can Tho, VietnamFaculty of Pharmacy, Can Tho University of Medicine and Pharmacy, 900000 Can Tho, VietnamFaculty of Medicine, Can Tho University of Medicine and Pharmacy, 900000 Can Tho, VietnamObjective: This review was conducted to explain how menopausal hormone therapy (MHT) benefits cardiovascular diseases (CVDs) and how to control the risk of breast cancer. Mechanism: Estrogen deficiency, altered energy homeostasis, adipocyte changes, inflammation, and insulin resistance are responsible for the development of metabolic syndrome and CVDs. Estrogen influences hypothalamic function and maintains the energy balance, protecting menopausal women from these cardiovascular risk factors. However, estrogen metabolism plays a crucial role in the genotoxic pathway that leads to breast cancer. Moreover, MHT is associated with cell proliferation and mutation signaling pathways in breast cancer, as well as the process of growing the breast cancer stem cell. Findings in Brief: While MHT may have favorable effects when started early, introducing it later in the course of atherosclerosis may pose major dangers, underlining the importance of timing in hormone therapy. Estrogen-only therapy has a greater favorable effect on CVDs than the estrogen-progesterone combination. Although the connection between MHT and breast cancer is well-documented, significant knowledge gaps remain, especially regarding the long-term effects of newer MHT formulations. Current studies support using the lowest effective dose for the shortest possible duration, with a focus on tailoring therapy to individual risk factors, such as obesity, smoking, and alcohol consumption. Thus, MHT should be customized due to the intricacy of individual risk factors and differences in responses to therapy. Conclusions: Although MHT is effective for controlling CVDs in women entering menopause, it must be used with caution, especially in women at high risk of breast cancer.https://www.imrpress.com/journal/CEOG/52/1/10.31083/CEOG26813atherosclerosiscardiovascular risk factorsmenopausal womenobesityestradiolcell proliferationmutation |
| spellingShingle | Tam Thai Thanh Tran Thu Minh Phung Anh Thi Mai Do Quynh Tran Mai Ly Tin Hoang Nguyen Menopausal Hormone Therapy: Its Role in the Prevention of Cardiovascular Diseases and the Risk of Breast Cancer in Women Clinical and Experimental Obstetrics & Gynecology atherosclerosis cardiovascular risk factors menopausal women obesity estradiol cell proliferation mutation |
| title | Menopausal Hormone Therapy: Its Role in the Prevention of Cardiovascular Diseases and the Risk of Breast Cancer in Women |
| title_full | Menopausal Hormone Therapy: Its Role in the Prevention of Cardiovascular Diseases and the Risk of Breast Cancer in Women |
| title_fullStr | Menopausal Hormone Therapy: Its Role in the Prevention of Cardiovascular Diseases and the Risk of Breast Cancer in Women |
| title_full_unstemmed | Menopausal Hormone Therapy: Its Role in the Prevention of Cardiovascular Diseases and the Risk of Breast Cancer in Women |
| title_short | Menopausal Hormone Therapy: Its Role in the Prevention of Cardiovascular Diseases and the Risk of Breast Cancer in Women |
| title_sort | menopausal hormone therapy its role in the prevention of cardiovascular diseases and the risk of breast cancer in women |
| topic | atherosclerosis cardiovascular risk factors menopausal women obesity estradiol cell proliferation mutation |
| url | https://www.imrpress.com/journal/CEOG/52/1/10.31083/CEOG26813 |
| work_keys_str_mv | AT tamthaithanhtran menopausalhormonetherapyitsroleinthepreventionofcardiovasculardiseasesandtheriskofbreastcancerinwomen AT thuminhphung menopausalhormonetherapyitsroleinthepreventionofcardiovasculardiseasesandtheriskofbreastcancerinwomen AT anhthimaido menopausalhormonetherapyitsroleinthepreventionofcardiovasculardiseasesandtheriskofbreastcancerinwomen AT quynhtranmaily menopausalhormonetherapyitsroleinthepreventionofcardiovasculardiseasesandtheriskofbreastcancerinwomen AT tinhoangnguyen menopausalhormonetherapyitsroleinthepreventionofcardiovasculardiseasesandtheriskofbreastcancerinwomen |